rs148216086
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 1P and 10B. PM4_SupportingBP6_ModerateBA1
The NM_005015.5(OXA1L):c.1265_1267dup(p.Ser422dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,611,336 control chromosomes in the GnomAD database, including 60,630 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.25 ( 4869 hom., cov: 24)
Exomes 𝑓: 0.27 ( 55761 hom. )
Consequence
OXA1L
NM_005015.5 inframe_insertion
NM_005015.5 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.11
Genes affected
OXA1L (HGNC:8526): (OXA1L mitochondrial inner membrane protein) This gene encodes an evolutionarily conserved protein that is localized to the inner mitochondrial membrane. The encoded protein is essential for the translocation of the N-terminal tail of subunit 2 of cytochrome c oxidase, and is involved in the assembly of the cytochrome c oxidase and ATPase complexes of the mitochondrial respiratory chain. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_005015.5. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 14-22771504-T-TAGC is Benign according to our data. Variant chr14-22771504-T-TAGC is described in ClinVar as [Benign]. Clinvar id is 403461.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.35 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OXA1L | NM_005015.5 | c.1265_1267dup | p.Ser422dup | inframe_insertion | 10/10 | ENST00000612549.6 | NP_005006.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OXA1L | ENST00000612549.6 | c.1265_1267dup | p.Ser422dup | inframe_insertion | 10/10 | 1 | NM_005015.5 | ENSP00000483491 | P1 |
Frequencies
GnomAD3 genomes AF: 0.249 AC: 37865AN: 151794Hom.: 4865 Cov.: 24
GnomAD3 genomes
AF:
AC:
37865
AN:
151794
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.257 AC: 64521AN: 251312Hom.: 8792 AF XY: 0.266 AC XY: 36094AN XY: 135812
GnomAD3 exomes
AF:
AC:
64521
AN:
251312
Hom.:
AF XY:
AC XY:
36094
AN XY:
135812
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.274 AC: 400026AN: 1459424Hom.: 55761 Cov.: 33 AF XY: 0.278 AC XY: 201730AN XY: 726078
GnomAD4 exome
AF:
AC:
400026
AN:
1459424
Hom.:
Cov.:
33
AF XY:
AC XY:
201730
AN XY:
726078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.249 AC: 37896AN: 151912Hom.: 4869 Cov.: 24 AF XY: 0.249 AC XY: 18478AN XY: 74266
GnomAD4 genome
AF:
AC:
37896
AN:
151912
Hom.:
Cov.:
24
AF XY:
AC XY:
18478
AN XY:
74266
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
964
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at